LCM
IDYA icon

Laurion Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Laurion Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,300
Closed -$156K – 1031
2019
Q3 		$156K Sell
17,300
-2,700
-14% -$20.6K ﹤0.01% 938
2019
Q2 		$199K Buy
+20,000
New +$218K ﹤0.01% 828

Other funds holding IDYA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Laurion Capital Management's IDYA Position: Q4 2019 in Review

Laurion Capital Management sold out of IDEAYA Biosciences (IDYA) in Q4 2019, closing a stake of 17,300 shares — an estimated $156K sold.

Laurion Capital Management first reported a position in IDYA in Q2 2019 and held it in 2 quarters. The position peaked at $199K in Q2 2019. 29 funds tracked by Wall St. Rank hold IDYA as of Q4 2019.

  • Laurion Capital Management reported no remaining IDEAYA Biosciences position as of Q4 2019 after selling out during the quarter.
  • Laurion Capital Management sold 17,300 IDEAYA Biosciences shares in Q4 2019, an estimated $156K.
  • Laurion Capital Management first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 2 quarters.
  • Laurion Capital Management's IDEAYA Biosciences position peaked at $199K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2019.

Based on Laurion Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.